Trials / Unknown
UnknownNCT06258746
Pharmacokinetics, Mass Balance, and Metabolism of [14C]HSK31679 in Healthy Adult Male Volunteers.
A Clinical Study on Absorption, Metabolism, and Excretion of [14C]HSK31679 in Healthy Adult Male Chinese Subjects - Mass Balance and Biotransformation of [14C]HSK31679 in Human
- Status
- Unknown
- Phase
- Phase 1
- Study type
- Interventional
- Enrollment
- 6 (actual)
- Sponsor
- Xizang Haisco Pharmaceutical Co., Ltd · Industry
- Sex
- Male
- Age
- 18 Years – 45 Years
- Healthy volunteers
- Accepted
Summary
This is a single-center, nonrandomized, and open design study to investigate the pharmacokinetics, mass balance, metabolism and excretion of HSK31679 in healthy male subjects.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | [14C]HSK31679 | A single oral dose of 160 mg/100 μCi \[14C\]HSK31679 after fasting for at least 10 hours. |
Timeline
- Start date
- 2023-12-05
- Primary completion
- 2023-12-21
- Completion
- 2024-12-30
- First posted
- 2024-02-14
- Last updated
- 2024-08-20
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06258746. Inclusion in this directory is not an endorsement.